Fundz

Trellis Bioscience

Redwood City, California, United States · Biotechnology, Health Care

Trellis Bioscience is a clinical-stage biotechnology company focused on developing native human monoclonal antibodies (mAbs) to treat intractable infectious diseases. The company is currently advancing its investigational treatment, calpurbatug (TRL1068), for chronic prosthetic joint infections. With substantial funding from various investors, Trellis aims to redefine the treatment for antibiotic-

Key facts

Headquarters
Redwood City, California, United States
Employees
17
Industries
Biotechnology, Health Care
Status
Private
Website
trellisbio.com
LinkedIn
Company page

Recent activity at Trellis Bioscience

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Trellis Bioscience funding history

DateRoundAmount
Jul 2026Series C$9.0M
Apr 2023Venture$1.4M
Jun 2022Venture$985K
Apr 2010Venture$22.9M

Leadership

  • Stefan, President & CEO
  • Geoffrey, Chief Business Officer

Verified email and direct lines for Trellis Bioscience’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Trellis Bioscience files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Companies similar to Trellis Bioscience

About Trellis Bioscience: questions and answers

What does Trellis Bioscience do?

Trellis Bioscience is a clinical-stage biotechnology company focused on developing native human monoclonal antibodies (mAbs) to treat intractable infectious diseases. The company is currently advancing its investigational treatment, calpurbatug (TRL1068), for chronic prosthetic joint infections. With substantial funding from various investors, Trellis aims to redefine the treatment for antibiotic-

Where is Trellis Bioscience headquartered?

Trellis Bioscience is headquartered in Redwood City, California, United States.

How many employees does Trellis Bioscience have?

Trellis Bioscience has about 17 employees.

Has Trellis Bioscience raised funding?

Yes. Fundz has recorded 4 funding events for Trellis Bioscience. The most recent, Series C of $9.0M, was in Jul 2026.

Who leads Trellis Bioscience?

Stefan is a President & CEO at Trellis Bioscience.

What is the latest news on Trellis Bioscience?

On Jul 16, 2026, Trellis Bioscience raises $9 million in Series C funding to advance clinical development of Calpurbatug (TRL1068), targeting antibiotic-resistant infections. New and existing investors including AMR Action Fund and New Science Ventures participated.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Trellis Bioscience across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.